Variant report
Variant | nsv945748 |
---|---|
Chromosome Location | chr1:47858512-47862980 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr1:47861286..47863513-chr1:47865315..47867381,2 | MCF-7 | breast: | |
2 | chr1:47861125..47863393-chr1:47873885..47875951,2 | MCF-7 | breast: | |
3 | chr1:47859231..47861431-chr1:47871606..47874283,2 | K562 | blood: | |
4 | chr1:47857694..47860292-chr1:47903399..47906596,3 | K562 | blood: |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-STIL-5 | chr1:47859450-47861215 | NONHSAT003079 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000225762 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs565947697 | chr1:47858528-47858529 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs141167289 | chr1:47858741-47858742 | Weak transcription Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs573776568 | chr1:47858752-47858753 | Weak transcription Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs551349236 | chr1:47858773-47858774 | Weak transcription Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs560066999 | chr1:47858804-47858805 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs11323397 | chr1:47858815-47858816 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs10890479 | chr1:47858821-47858822 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs192590658 | chr1:47858908-47858909 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs555145978 | chr1:47858935-47858936 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs369097544 | chr1:47858978-47858979 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs573700398 | chr1:47859004-47859005 | Flanking Active TSS Bivalent Enhancer Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs552833600 | chr1:47859036-47859037 | Flanking Active TSS Bivalent Enhancer Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs143234614 | chr1:47859062-47859063 | Flanking Active TSS Bivalent Enhancer Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs183497109 | chr1:47859094-47859095 | Flanking Active TSS Bivalent Enhancer Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs572892057 | chr1:47859118-47859119 | Flanking Active TSS Bivalent Enhancer Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs577866882 | chr1:47859127-47859128 | Flanking Active TSS Bivalent Enhancer Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs369426675 | chr1:47859170-47859171 | Flanking Active TSS Bivalent Enhancer Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs148336348 | chr1:47859181-47859182 | Flanking Active TSS Bivalent Enhancer Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs544659399 | chr1:47859234-47859235 | Bivalent Enhancer Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs575220718 | chr1:47859341-47859342 | Bivalent Enhancer Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs543038543 | chr1:47859392-47859393 | Bivalent Enhancer Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs564549270 | chr1:47859412-47859413 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs561198081 | chr1:47859421-47859422 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs528603669 | chr1:47859426-47859427 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs547235743 | chr1:47859469-47859470 | Weak transcription Enhancers | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs559592395 | chr1:47859534-47859535 | Weak transcription Enhancers | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs533202429 | chr1:47859596-47859597 | Weak transcription Enhancers | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs2820991 | chr1:47859600-47859601 | Weak transcription Enhancers | Chromatin interactive regionlncRNA | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs554719890 | chr1:47859623-47859624 | Weak transcription Enhancers | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs150886174 | chr1:47859624-47859625 | Weak transcription Enhancers | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs536614621 | chr1:47859643-47859644 | Weak transcription Enhancers | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs548977266 | chr1:47859644-47859645 | Weak transcription Enhancers | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs112440010 | chr1:47859654-47859655 | Weak transcription Enhancers | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs371903431 | chr1:47859664-47859665 | Weak transcription Enhancers | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs138257476 | chr1:47859665-47859666 | Weak transcription Enhancers | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs2820992 | chr1:47859686-47859687 | Weak transcription Enhancers | Chromatin interactive regionlncRNA | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs577809585 | chr1:47859701-47859702 | Weak transcription Enhancers | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs188278532 | chr1:47859704-47859705 | Weak transcription Enhancers | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs557211757 | chr1:47859718-47859719 | Weak transcription Enhancers | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs575556312 | chr1:47859753-47859754 | Weak transcription Enhancers | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs181103699 | chr1:47859782-47859783 | Weak transcription Enhancers | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs561344884 | chr1:47859808-47859809 | Weak transcription Enhancers | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs573210886 | chr1:47859880-47859881 | Weak transcription Enhancers | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs115129409 | chr1:47859931-47859932 | Weak transcription Enhancers | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs565412098 | chr1:47859937-47859938 | Weak transcription Enhancers | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs147315354 | chr1:47860010-47860011 | Weak transcription Enhancers | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs545245177 | chr1:47860027-47860028 | Weak transcription Enhancers | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs184955874 | chr1:47860028-47860029 | Weak transcription Enhancers | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs563540283 | chr1:47860044-47860045 | Weak transcription Enhancers | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs528587576 | chr1:47860045-47860046 | Weak transcription Enhancers | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Glioblastoma multiforme | 21080181 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 17603634 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
Papillary thyroid carcinoma | 21436994 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Wilms tumour | 21544195 | CNVD |
Coronary Disease | 20032323 | CNVD |
Prostate cancer | 21965145 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Stargardt''s disease | 17277736 | CNVD |
Neuroblastoma | 17897457 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-syndromic sensorineural hearing loss | 22290220 | CNVD |
Liposarcoma | 21253554 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Astrocytoma | 17387387 | CNVD |
Cancer | 21499728 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Neuroblastoma | 17535989 | CNVD |
Pheochromocytoma | 17535989 | CNVD |
Prostate cancer | 16705090 | CNVD |
Astrocytoma | 17934521 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Autism | 22495311 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Chordoma | 21602918 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Melanoma | 18172304 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Melanoma | 17363583 | CNVD |
Cancer | 21129771 | CNVD |
Autosomal dominant nocturnal frontal lobe epilepsy | 18472482 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Thrombocytopenia-absent radius syndrome | 21933853 | CNVD |
Psychiatric disorder | 22848183 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 20409316 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17393978 | CNVD |
Cervical cancer | 21062161 | CNVD |
Cancer | 21183584 | CNVD |
Muscle-eye-brain disease | 21572526 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelofibrosis | 22110671 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21364760 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Glioblastoma | 20031968 | CNVD |
Leukemia | 18688285 | CNVD |
Rett syndrome | 21593744 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Meckel-Gruber syndrome | 21572526 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:47847400-47858600 | Weak transcription | Muscle Satellite Cultured Cells | -- |
2 | chr1:47847600-47858800 | Weak transcription | HSMMtube | muscle |
3 | chr1:47847600-47865200 | Weak transcription | GM12878-XiMat | blood |
4 | chr1:47847600-47872800 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
5 | chr1:47849400-47858800 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
6 | chr1:47856600-47861400 | Weak transcription | Foreskin Melanocyte Primary Cells skin01 | Skin |
7 | chr1:47857000-47858800 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
8 | chr1:47858400-47860200 | Enhancers | HSMM | muscle |
9 | chr1:47858600-47859400 | Bivalent Enhancer | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
10 | chr1:47858600-47859400 | Enhancers | Muscle Satellite Cultured Cells | -- |
11 | chr1:47858800-47859000 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
12 | chr1:47858800-47859200 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
13 | chr1:47858800-47859200 | Enhancers | HSMMtube | muscle |
14 | chr1:47859000-47859200 | Flanking Active TSS | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
15 | chr1:47859000-47859200 | Enhancers | Foreskin Fibroblast Primary Cells skin02 | Skin |
16 | chr1:47859000-47859400 | Enhancers | Placenta Amnion | Placenta Amnion |
17 | chr1:47860600-47861800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
18 | chr1:47861400-47861800 | Enhancers | Foreskin Melanocyte Primary Cells skin01 | Skin |
19 | chr1:47862400-47866600 | Weak transcription | Fetal Intestine Small | intestine |